SCHEMBL18529785

SCHEMBL18529785

CN(C(=O)O)c1cc2cc(-c3ccc(C(=O)N4CCC(F)(F)CC4)cc3)cc(-c3ccc(F)cc3)c2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK4 O96013 2/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ PAK1 Q13153 1/20 0.43
▸ TDO2 P48775 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ GPR183 P32249 7/20 0.39
▸ SLC6A7 Q99884 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ FASN P49327 1/20 0.38
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ USP2 O75604 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18529794 0.81 PAK4 (0.48) PAK4NAMPTPAK1TDO2HDAC3
SCHEMBL18529792 0.80 PAK4 (0.42) PAK4NAMPTPAK1HDAC3HDAC1
SCHEMBL19066884 0.80 PAK4 (0.52) PAK4NAMPTPAK1HDAC3HDAC1
SCHEMBL17844708 0.80 PAK4 (0.42) PAK4NAMPTPAK1HDAC3HDAC1
SCHEMBL18529784 0.80 PAK4 (0.49) PAK4NAMPTPAK1TDO2HDAC3
SCHEMBL17844683 0.77 PAK4 (0.41) PAK4NAMPTPAK1HSD11B1SLC6A7
SCHEMBL18530503 0.76 PAK4 (0.41) PAK4NAMPTPAK1TDO2HDAC3
SCHEMBL18541372 0.75 PAK4 (0.46) PAK4NAMPTPAK1HDAC3HDAC1
SCHEMBL21166248 0.74 SLC6A7 (0.57) HSD11B1GPR183SLC6A7MEN1KMT2A
SCHEMBL19066871 0.74 PAK4 (0.45) PAK4NAMPTPAK1TDO2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017031204-A1 CYCLOPROPYLDERIVATIVES AND THEIR USE AS KINASE INHIBITORS Karyopharm Therapeutics Inc. (US) 2017-02-23 — — WO disclosed
Send feedback